Clinical Trial Update: Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS") [NA]

View source ↗

Summary

A completed clinical trial evaluating pharmacokinetics and pharmacodynamics of an extended wear subcutaneous insulin infusion set in adults with type 1 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Capillary Biomedical, Inc. | Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2022-08-09